Baltic18 features top research in and beyond the region An overview report on the meeting’s fifth edition Dr. Peteris Vaganovs Chairman of the 5th Baltic Meeting in conjunction with the EAU Riga (LV)
androgen deprivation therapy (ADT) in biochemical relapse and possibly delay progression in oligometastatic hormone-resistant PCa. Mežeckis also emphasised that careful examination, including positron emission tomography–computed tomography (PET-CT), is mandatory in detecting all subclinical lesions in the body.
peteris.vaganovs@ gmail.com
In her lecture, Dr. Ruta Austeja Lenkaityte (LT) stated that all eligible patients with intermediate to high-risk PCa should be offered external beam radiotherapy (EBRT) plus brachytherapy boost. High-dose rate brachytherapy (HDR-BT) monotherapy is effective using multiple fractions but further investigation is needed to assess the effectiveness and late toxicities of between oneand two-fraction schemes.
The 5th Baltic Meeting in conjunction with the EAU (Baltic18) took place in historic Riga, Latvia, a serendipitous event as my country will celebrate the centenary of its proclamation of independence this year. I, along with the meeting’s esteemed faculty, welcomed participants for a two-day meeting centred on the latest developments in urology and its subspecialties. Male infertility updates Baltic18 commenced with the EAU Lecture “Where are we in male infertility in 2018?” by EAU Adjunct Secretary General – Clinical Practice Prof. Jens Sønksen (DK), who stated that endocrine disruptors and the testicular dysgenesis syndrome might be a common underlying cause for infertility, cryptorchidism, hypospadias and testis cancer. Moreover, male infertility is associated with a two-fold increased risk for testis cancer: both the cancer and its treatment may adversely affect fertility. Fertility preservation for testis cancer is mandatory. Baltic expert presentations The session “Advances in imaging radiotherapy on prostate cancer” chaired by Dr. Martin Kivi (EE) and Assoc. Prof. Egils Vjaters (LV) highlighted innovative research of experts from the Baltic region.
According to Dr. Marika Kalniņa (LV), 68GA-PSMA PET/ CT imaging is superior to choline-PET and standard imaging procedures for lymph node and bone staging. However, small-sized lesions can still be missed. Nonetheless, 68Ga-PSMA PET-CT shows great promise in improving PCa care.
BALTIC 18
www.baltic18.org
Dr. M. Kalnina answers questions from the panel
research and the second day of the meeting, Dr. Taavi Põdramägi (EE) was named prize winner. Recipients of the Berlin Chemie Best Poster included Ms. Kristina Stuopelyte (LT), et al. at first place with the poster “Blood-circulating androgen receptor variants as markers for progression and response to treatment in prostate cancer patients”; Mr. Arnas Bakavicius, et al. at second place for “Epigenetic markers to overcome limitations in prostate cancer diagnostics”; and at third place, Dr. Zane Pilsetniece (LT), et al. for “The influence of specific urinary incontinence type on the quality of life of incontinent women”.
Top awards Baltic18 brought together promising talent during the Young Urologists Competition, which was chaired by Dr. Teemu Murtola (FI) and Dr. Juan Luis Vásquez (DK). Four up-and-coming urologists presented their The prizes of the Karl Storz Best Poster were given to Dr. Minija Cerskute, et al. for “Laparoscopic pyeloplasty combined with flexible nephroscopy” at first place; Dr. Jack Donati-Bourne, et al. for “Prostate resection speed in TURP – how determining is this for patients and how appropriate as a measure for assessing trainees?” at second place; and Dr. Martin Kivi, et al. for “Laparoscopic left adrenalectomy. Adrenal ganglioneuroma” at third place.
Dr. Maris Mežeckis (LV) presented the benefits of CyberKnife robotic radiosurgery as a safe and effective treatment for solitary and oligometastatic prostate cancer (PCa) which can postpone the need for Popularity of the Baltic meetings increases every year
PCa state-of-the-art lecture Prof. Nicolas Mottet (FR), Chairman of the EAU Working Group on Prostate Cancer, shared an abridgment of the latest PCa updates based on recommendations in the new 2018 EAU Guidelines
during his state-of-the-lecture. Updates included offering further risk-assessment to asymptomatic men with a normal digital rectal examination (DRE) and a prostate-specific antigen (PSA) level between 2-10 ng/ mL prior to performing a prostate biopsy wherein multiparametric magnetic resonance imaging (mpMRI) is only as an option. However, for repeat biopsy following a negative one, mpMRI is strongly recommended beforehand. ESU activities The European School of Urology (ESU), together with the EAU Section of Uro-Technology (ESUT) organised the two Hands-on Training sessions ESU/ESUT Hands-on Training in laparoscopy and ESU/ESUT Hands-on training in Ureterorenoscopy for Baltic18 complemented by the ESU Course on bladder cancer which was spearheaded by ESU Chairman, Dr. Joan Palou (ES). On behalf of the rest of the Baltic18 faculty, thank you for your support and participation! Mark the 24th and 25th of May 2019 in your calendars for the 6th edition of the Baltic Meeting in picturesque Tallinn, Estonia.
EAU Secretary General, Prof. C. Chapple deliberates with faculty
www.cem18.org
www.seem18.org
CEM18
SEEM18
EAU 18th Central European Meeting in conjunction with the national congress of the Romanian Association of Urology
EAU 13th South Eastern European Meeting 21-22 September 2018, Belgrade, Serbia
12 October 2018, Cluj Napoca, Romania
An application has been made to the EACCME® for CME accreditation of this event
An application has been made to the EACCME® for CME accreditation of this event
Call for Abstracts
Register for the early fee!
Deadline 15 July 2018
Deadline 1 August 2018
June/July 2018
25-26 May 2018 Riga, Latvia
European Urology Today
37